Humanigen Inc (fka HGENQ)

[cowtown jay]

More news on magrolimab.

"US FDA puts Gilead Sciences blood cancer drug studies on hold
Reuters
August 21, 2023

Gilead Sciences (GILD.O) said on Monday the U.S. health regulator placed a clinical hold on studies of its blood cancer drug, just a month after the company scrapped a late-stage trial due to efficacy concerns.

The company gained access to the drug, magrolimab, with its $4.9 billion buyout of Forty Seven Inc in March 2020.

The company said the U.S. Food and Drug Administration (FDA) had paused screening and enrollment of new study participants, while the patients already under the studies may continue to receive treatment."

https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-puts-gilead-sciences-blood-cancer-drug-studies-hold-2023-08-21/